Why is there a supplement craze if they don't even work?

Summary

This Planet Money episode investigates the U.S. supplement boom by asking whether Sarah Gonzalez and Jane Black could make a real branded supplement. The reporting shows that white-label and custom supplement manufacturing can be surprisingly easy, while Dietary Supplement Regulation lets firms imply broad wellness benefits through Supplement Structure Function Claims without proving drug-like effectiveness before sale. The strongest case study is Prevagen: the episode uses it to connect [[FoodAndDrugAdministration|FDA]] limits, GRAS Self-Certification, slow [[FederalTradeCommission|FTC]] advertising enforcement, label uncertainty, and consumer belief in products that may mostly work through Supplement Placebo Effect.

Key Claims

• The episode says the U.S. supplement industry is worth about $70 billion, that about 75% of Americans take supplements, and that consumers face roughly 100,000 product options.
• Frank Cantone explains that a seller can make capsules, tablets, powders, soft gels, or gummies under its own label, either through a fully customized batch or a cheaper stock formula.
• The manufacturing discussion shows how Recurring Supplement Commerce works: monthly reorders can make supplements more attractive than products consumers buy only occasionally.
• The reporting distinguishes targeted medical use from broad wellness claims: folic acid during pregnancy and doctor-recommended supplementation for deficiencies are treated differently from supplements marketed to already healthy people.
• The episode frames the Dietary Supplement Health and Education Act as the turning point that made supplement oversight unusually permissive.
• Supplement makers can use words such as “supports” or “promotes” if they avoid disease-treatment words such as diagnose, prevent, cure, treat, or mitigate.
• Labels can say claims have not been evaluated by the [[FoodAndDrugAdministration|FDA]], yet consumers may still read the package as if the benefit were proven.
• For new supplement ingredients, the source says the legal threshold is weaker than drug approval: the ingredient generally must be reasonably expected to be safe, not proven effective.
• Melanie Benish uses Prevagen and NeuroShake to show how food-law GRAS Self-Certification can interact with supplement sales after FDA safety concerns.
• The [[FederalTradeCommission|FTC]] sued over Prevagen advertising in 2017 and, according to the episode, won almost eight years later after the cited clinical trial failed to show memory improvement.
• Marion Nestle argues that many supplement labels may not reliably match contents, making Supplement Label Accuracy a practical consumer problem rather than only a scientific-efficacy question.
• The episode cites Consumer Lab findings of wide variation in turmeric, echinacea, and elderberry supplements, including elderberry products on Amazon that did not contain authentic elderberry.
• The source warns that “natural” or familiar supplements can still carry risks, especially concentrated green tea EGCG extract and high-dose turmeric, making Herbal Supplement Liver Toxicity part of the safety discussion.
• Third-Party Supplement Testing through marks such as [[NSFInternational|NSF]] or [[UnitedStatesPharmacopeia|USP]] may help verify listed ingredients and contamination levels, but it does not prove a supplement makes healthy people healthier.

Key Quotes

“supports metabolism” - Frank Cantone’s example of acceptable claim language.

“supports” or “promotes” - Melanie Benish on wording that should signal an unproven supplement claim.

“no evidence supplements make healthy people healthier” - Marion Nestle’s bottom-line skepticism as summarized in the episode.

Connections

• NPR and Planet Money - network and show context.
• Sarah Gonzalez and Jane Black - host and reporter framing the investigation.
• Frank Cantone - manufacturer explaining custom formulas, stock formulas, claim phrasing, and recurring economics.
• Marion Nestle - nutrition scholar providing the skeptical evidence and label-reliability frame.
• Melanie Benish and Environmental Working Group - regulatory-law voice and organization behind the DSHEA, FDA, and Prevagen discussion.
• Food and Drug Administration and Federal Trade Commission - agencies whose different powers shape safety and advertising enforcement.
• Prevagen, Mark Underwood, and NeuroShake - case study for the jellyfish-protein memory supplement and GRAS route.
• Consumer Lab, NSF International, and United States Pharmacopeia - testing and verification layer.
• Dietary Supplement Regulation, Dietary Supplement Health and Education Act, Supplement Structure Function Claims, and GRAS Self-Certification - regulatory architecture added by the source.
• Supplement Label Accuracy, Herbal Supplement Liver Toxicity, Third-Party Supplement Testing, and Supplement Placebo Effect - consumer-risk and evidence concepts added by the source.
• Medical AI Marketing Risk and Online Healthcare Regulatory Boundary - adjacent health-trust and regulatory-boundary pages this source extends beyond AI and online care.

Contradictions

• No direct contradiction found.
• The source qualifies broad supplement skepticism by preserving exceptions for pregnancy-related folic acid and clinically identified deficiencies.
• The source extends Medical AI Marketing Risk without contradicting it: health-marketing authority problems existed before AI, and AI can amplify but does not create the underlying claim-evidence gap.